FSAGX
Price
$38.74
Change
+$0.22 (+0.57%)
Updated
Jul 3 closing price
Net Assets
2.36B
RYMPX
Price
$153.17
Change
+$0.94 (+0.62%)
Updated
Jul 3 closing price
Net Assets
119.52M
Interact to see
Advertisement

FSAGX vs RYMPX

Header iconFSAGX vs RYMPX Comparison
Open Charts FSAGX vs RYMPXBanner chart's image
Fidelity Select Gold
Price$38.74
Change+$0.22 (+0.57%)
VolumeN/A
Net Assets2.36B
Rydex Precious Metals H
Price$153.17
Change+$0.94 (+0.62%)
VolumeN/A
Net Assets119.52M
FSAGX vs RYMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSAGX vs. RYMPX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSAGX is a StrongBuy and RYMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSAGX has more cash in the bank: 2.36B vs. RYMPX (120M). FSAGX pays higher dividends than RYMPX: FSAGX (2.21) vs RYMPX (0.00). FSAGX was incepted earlier than RYMPX: FSAGX (40 years) vs RYMPX (22 years). RYMPX (1.58) is less costly to investors than FSAGX (0.68). RYMPX is a more actively managed with annual turnover of: 387.00 vs. FSAGX (17.00). FSAGX has a lower initial minimum investment than RYMPX: FSAGX (0) vs RYMPX (2500). FSAGX annual gain was more profitable for investors over the last year : 63.33 vs. RYMPX (46.55). FSAGX return over 5 years is better than : 42.85 vs. RYMPX (39.47).
FSAGXRYMPXFSAGX / RYMPX
Total Expense Ratio0.681.5544%
Annual Report Gross Expense Ratio0.681.5843%
Fund Existence40 years22 years-
Gain YTD57.60852.864109%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets2.36B120M1,965%
Annual Yield % from dividends2.210.00-
Returns for 1 year63.3346.55136%
Returns for 3 years88.9672.21123%
Returns for 5 years42.8539.47109%
Returns for 10 years166.74149.23112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMNOX45.950.47
+1.03%
Patient Opportunity I
VYSAX14.890.13
+0.88%
Voya Small Company I
FAPKX12.730.07
+0.55%
Fidelity Advisor Healthy Future C
LVAQX18.850.10
+0.53%
LSV Small Cap Value Investor
DEMCX24.180.03
+0.12%
Macquarie Emerging Markets C